Untitled Letters 2022
These letters are supplied by the CDER Freedom of Information Office and only covers Office of Prescription Drug Promotion's untitled letters. The agency may have redacted or edited some of the letters to remove confidential information.
Office of Prescription Drug Promotion
| Company / Individual | Product / Issue | Issued Date |
|---|---|---|
|
Truliciity
|
BLA 125469 TRULICITY® (dulaglutide) injection, for subcutaneous use |
01/19/2022 |
